Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
N Engl J Med. 2020 Sep 17;383(12):1117-1128. doi: 10.1056/NEJMoa2001180.
N Engl J Med. 2020.
PMID: 32937045
Clinical Trial.